Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-19-012302
Filing Date
2019-08-14
Accepted
2019-08-14 07:07:08
Documents
69
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 520083
2 ex31-1.htm EX-31.1 16523
3 ex32-1.htm EX-32.1 7576
  Complete submission text file 0001493152-19-012302.txt   3010439

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE FILE biopl-20190630.xml EX-101.INS 540701
5 XBRL SCHEMA FILE biopl-20190630.xsd EX-101.SCH 41840
6 XBRL CALCULATION FILE biopl-20190630_cal.xml EX-101.CAL 57811
7 XBRL DEFINITION FILE biopl-20190630_def.xml EX-101.DEF 122253
8 XBRL LABEL FILE biopl-20190630_lab.xml EX-101.LAB 230034
9 XBRL PRESENTATION FILE biopl-20190630_pre.xml EX-101.PRE 204894
Mailing Address NO.9 & 10, JALAN P4/8B BANDAR TEKNOLOGI KAJANG SEMENYIH, SELANGOR N8 43500
Business Address NO.9 & 10, JALAN P4/8B BANDAR TEKNOLOGI KAJANG SEMENYIH, SELANGOR N8 43500 60387032020
BIOPLUS LIFE CORP. (Filer) CIK: 0001746214 (see all company filings)

EIN.: 300987011 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 333-226885 | Film No.: 191022789
SIC: 5912 Retail-Drug Stores and Proprietary Stores